This study illustrates that enhancing the function of Cx40 channels may increase the sensitivity of tumor cells to PDT and suggests that treatment strategies designed to increase the expression of Cx40 or to sustain the functionality of Cx40 channels might increase PDT treatment outcome. The gene discussed is GJA5; the disease is neoplasm.